Venus Remedies, A Provider Of Affordable Cancer Drugs Worldwide, Has Secured Marketing Authorisation From The Uk For Cisplatin, A Chemotherapy Drug Used As A First-Line Treatment For Advanced Ovarian Cancer, Testicular Cancer And Bladder Carcinoma. This Marketing Authorisation Granted To Venus Pharma Gmbh, The German Subsidiary Of Venus Remedies, By One Of The World
